Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021

SELL
$79.17 - $111.47 $197,925 - $278,675
-2,500 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$81.91 - $134.94 $40,955 - $67,470
500 Added 25.0%
2,500 $258,000
Q2 2020

Jul 14, 2020

BUY
$54.33 - $89.52 $108,660 - $179,040
2,000 New
2,000 $158,000
Q1 2019

May 06, 2019

SELL
$48.23 - $66.16 $289,380 - $396,960
-6,000 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$52.05 - $66.51 $52,050 - $66,510
1,000 Added 20.0%
6,000 $395,000
Q1 2018

May 15, 2018

SELL
$44.44 - $54.39 $266,640 - $326,340
-6,000 Reduced 54.55%
5,000 $6.49 Million
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $415,470 - $525,250
11,000
11,000 $511,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $404M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Brasada Capital Management, LP Portfolio

Follow Brasada Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brasada Capital Management, LP with notifications on news.